CLICK HERE FOR MORE HEALTH STORIES "So, in the setting of a person with ALS whether they have diabetes or not using GLP-1s may actually worsen the disease and make for a rapid progression." In a 2025 case report published in the medical journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, a 52-year-old ALS patient was prescribed semaglutide to treat her type 2 diabetes
Enko D, Meinitzer A, Mangge H, Kriegshuser G, Halwachs-Baumann G, Reininghaus EZ, et al
However, it is still sufficient to ensure rapid clearance of damaged erythrocytes and prevent their lytic cell death
call the office with any questions 208-930-6823
The standout weaknesses are a 26-day wait before my order shipped, dose-based pricing for tirzepatide, and support that is limited to email, with no phone or chat
Peptides (2018) 99:99107